Lepirudin for cardiopulmonary bypass surgery in a patient with terminal renal insufficiency and acute heparin-induced thrombocytopenia

被引：0
|
作者：
Riess, FC [1 ]
Dobritzsch, B [1 ]
Kormann, J [1 ]
机构：
[1] Albertinen Heart Ctr, D-22457 Hamburg, Germany
来源：
THORACIC AND CARDIOVASCULAR SURGEON | 2006年 / 54卷 / 02期
关键词：
hirudin; cardiopulmonary; bypass; renal failure; heparin-induced thrombocytopenia; hemofiltration;
D O I：
10.1055/s-2005-872806
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A patient with triple heart valve disease, heparin-induced thrombocytopenia, and terminal renal insufficiency was treated successfully using lepirudin for anticoagulation of cardiopulmonary bypass (CPB) and during the postoperative course. Anticoagulatory monitoring was performed with ecarin clotting time during CPB and aPTT postoperatively.
引用
收藏
页码：140 / 142
页数：3
相关论文
共 50 条
  • [21] The frequency of heparin-induced thrombocytopenia in Taiwanese patients undergoing cardiopulmonary bypass surgery
    Chen, Yeu-Chin
    Lin, Chih-Yuan
    Tsai, Chien-Sung
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2015, 114 (10) : 981 - 987
  • [22] Lepirudin in the management of patients with heparin-induced thrombocytopenia
    Petros, Sirak
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (03): : 481 - 490
  • [23] A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia
    Farner, B
    Eichler, P
    Kroll, H
    Greinacher, A
    THROMBOSIS AND HAEMOSTASIS, 2001, 85 (06) : 950 - 957
  • [24] Lepirudin use in a neonate with heparin-induced thrombocytopenia
    Nguyen, TN
    Gal, P
    Ransom, JL
    Carlos, R
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (02) : 229 - 233
  • [25] Heparin-induced thrombocytopenia in coronary bypass surgery
    Arnoletti, JP
    Whitman, GJR
    ANNALS OF THORACIC SURGERY, 1999, 68 (02): : 576 - 578
  • [26] MANAGEMENT OF PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA REQUIRING CARDIOPULMONARY BYPASS
    LONG, RW
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1985, 89 (06): : 950 - 951
  • [27] ANCROD ANTICOAGULATION FOR CARDIOPULMONARY BYPASS IN HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS
    TEASDALE, SJ
    ZULYS, VJ
    MYCYK, T
    BAIRD, RJ
    GLYNN, MFX
    ANNALS OF THORACIC SURGERY, 1989, 48 (05): : 712 - 713
  • [28] Cardiopulmonary bypass and heparin-induced thrombocytopenia: Pitfalls of anticoagulation with danaparoid
    Kanagasabay, R
    Unsworth-White, MJ
    Farnsworth, G
    Haxby, EJ
    Smith, EEJ
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2000, 120 (02): : 428 - 429
  • [29] Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass
    Lillo-de Louët, A
    Boutouyrie, P
    Alhenc-Gelas, M
    Le Beller, C
    Gautier, I
    Aiach, M
    Lasne, D
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (11) : 1882 - 1888
  • [30] Danaparoid for cardiopulmonary bypass in patients with previous heparin-induced thrombocytopenia
    Gillis, S
    Merin, G
    Zahger, D
    Deeb, M
    Drenger, B
    Hyam, E
    Eldor, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (03) : 657 - 659
12345